Lucintel Forecasts Neuromodulation Market To Grow At A Cagr Of 7%-9%

By Author: Lucintel LLC
Total Articles: 5674
Comment this article

According to the recent study the neuromodulation market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by increasing research and development activities in neurology and growing prevalence of neurological disorders.
Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in neuromodulation market by technology (internal neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation) and external neuromodulation (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES))), biomaterial (metallic biomaterials, polymeric biomaterials, and ceramic biomaterials), application (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation), and region (North America, ...
... Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx
“Internal neuromodulators market is expected to remain the largest segment during the forecast period.”
Based on technology, the neuromodulation market is segmented into internal neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation) and external neuromodulation (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES)). Lucintel forecasts that the internal neuromodulation market is expected to remain the largest segment during the forecast period due to rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness of neurodegenerative disorders.
“Within the neuromodulation market, the deep brain stimulation segment is expected to remain the largest application”
Based on application, the deep brain stimulation segment is expected to witness the largest segment over the forecast period due to the rising incidence of generic diseases and growing R&D activity for neuromodulation applications.
“North America will dominate the neuromodulation market in near future”
North America is expected to be the highest growth over the forecast period over the forecast period due to rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness of the safety and efficacy of neurostimulator devices in the region.
Download Brochure of this report by clicking on https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx
Major players of neuromodulation market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Medtronic, Boston Scientific, Abbott, LivaNova, Synapse Biomedical, Nevro, NeuroSigma, NeuroPace, Neuronetics, and BioControl Medical are among the major neuromodulation providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx